Did you know that more than half of your patients with type 2 diabetes have NAFLD?
As the prevalence of NAFLD continues to grow and the risk for NASH is significantly increased in patients with type 2 diabetes, it is important to screen all t…
7 May 2020
Provider Education Series
We've launched an educational and engaging provider education series as part of our continuing educational efforts during COVID-19: #1: How We Aid Doctors i…
27 Apr 2020
Guidance for trials using MRI during COVID-19
Clinical trial participants have been asking whether it is safe to get an MRI scan during the COVID-19 outbreak. New guidance for health systems was released o…
24 Apr 2020
Your Questions Answered: Clinical FAQ’S
Read our answers to frequently asked questions about LiverMultiScan. You might be wondering: Will it be approved by insurance? Reimbursement for an abdom…
23 Apr 2020
Perspectum Launches the First COVID-19 Recovery Study
Oxford, 21st April 2020. Perspectum, the leading medical imaging company, is launching the first study to map how COVID-19 impacts the health of multiple organ…
21 Apr 2020
How We Aid Doctors in the Diagnosis of Liver Disease
Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver diseases. With a strong focus on conditi…
15 Apr 2020
Press Release: Perspectum Closes $36M Financing Round co-led by Blue Venture Fund and HealthQuest Capital
Oxford, 14 April 2020. Perspectum® (“Perspectum” or “the Company”) a medical software company that provides non-invasive technology for identifying an…
14 Apr 2020
COVID-19; Inflammation and Obesity Links
Obesity is the biggest single chronic risk factor for hospital admission in patients under 60, increasing the risk 2-3-fold. Data from the CDC, supported by cl…
13 Apr 2020
Press Release: Gene identified as a potential target for drugs to prevent liver disease
The discovery of SLC39A8’s association with liver fibro-inflammatory disease could provide a new target for drug development for the prevention of liver dis…
8 Apr 2020
Press Release: 3T Radiology & Research and Perspectum Announce Partnership
Leading the Charge Against One of USA’s Most Common Undiagnosed Pre-Existing Health Conditions Dallas, Texas, April 9, 2020- Perspectum, a medical imaging…
8 Apr 2020
Video: An FDA-Cleared Non-Invasive Test for Liver Disease
Better serve your patients. LiverMultiScan, a non-invasive MRI technology, helps aid diagnosis of liver disease. LiverMultiScan has demonstrated accuracy an…
1 Apr 2020
Unrivalled quantitative MRI of the biliary tree could be the next generation in diagnosis and monitoring for patients with biliary disease
Oxford, 11th March, 2020. A new tool providing accurate and precise measurements over the entire biliary tree could address unmet needs in biliary diseases, la…
11 Mar 2020